8-64616016-C-G
Variant names: 
Variant summary
Our verdict is Likely pathogenic. The variant received 6 ACMG points: 6P and 0B. PM2PP3_Strong
The NM_004820.5(CYP7B1):c.525G>C(p.Trp175Cys) variant causes a missense change. The variant allele was found at a frequency of 0.00000658 in 151,990 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
 Genomes: 𝑓 0.0000066   (  0   hom.,  cov: 32) 
Consequence
 CYP7B1
NM_004820.5 missense
NM_004820.5 missense
Scores
 7
 10
 2
Clinical Significance
Conservation
 PhyloP100:  6.94  
Publications
0 publications found 
Genes affected
 CYP7B1  (HGNC:2652):  (cytochrome P450 family 7 subfamily B member 1) This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This endoplasmic reticulum membrane protein catalyzes the first reaction in the cholesterol catabolic pathway of extrahepatic tissues, which converts cholesterol to bile acids. This enzyme likely plays a minor role in total bile acid synthesis, but may also be involved in the development of atherosclerosis, neurosteroid metabolism and sex hormone synthesis. Mutations in this gene have been associated with hereditary spastic paraplegia (SPG5 or HSP), an autosomal recessive disorder. [provided by RefSeq, Apr 2016] 
CYP7B1 Gene-Disease associations (from GenCC):
- congenital bile acid synthesis defect 3Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), Orphanet
 - hereditary spastic paraplegia 5AInheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Genomics England PanelApp
 
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Likely_pathogenic. The variant received 6 ACMG points.
PM2
Very rare variant in population databases, with high coverage; 
PP3
MetaRNN computational evidence supports a deleterious effect, 0.988
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt | 
|---|---|---|---|---|---|---|---|---|
| CYP7B1 | NM_004820.5  | c.525G>C | p.Trp175Cys | missense_variant | Exon 3 of 6 | ENST00000310193.4 | NP_004811.1 | |
| CYP7B1 | NM_001324112.2  | c.525G>C | p.Trp175Cys | missense_variant | Exon 3 of 7 | NP_001311041.1 | ||
| CYP7B1 | XM_017014002.2  | c.591G>C | p.Trp197Cys | missense_variant | Exon 4 of 7 | XP_016869491.1 | 
Ensembl
Frequencies
GnomAD3 genomes   AF:  0.00000658  AC: 1AN: 151990Hom.:  0  Cov.: 32 show subpopulations 
GnomAD3 genomes 
 AF: 
AC: 
1
AN: 
151990
Hom.: 
Cov.: 
32
Gnomad AFR 
 AF: 
Gnomad AMI 
 AF: 
Gnomad AMR 
 AF: 
Gnomad ASJ 
 AF: 
Gnomad EAS 
 AF: 
Gnomad SAS 
 AF: 
Gnomad FIN 
 AF: 
Gnomad MID 
 AF: 
Gnomad NFE 
 AF: 
Gnomad OTH 
 AF: 
GnomAD4 exome Cov.: 33 
GnomAD4 exome 
Cov.: 
33
GnomAD4 genome   AF:  0.00000658  AC: 1AN: 151990Hom.:  0  Cov.: 32 AF XY:  0.00  AC XY: 0AN XY: 74228 show subpopulations 
GnomAD4 genome 
 AF: 
AC: 
1
AN: 
151990
Hom.: 
Cov.: 
32
 AF XY: 
AC XY: 
0
AN XY: 
74228
show subpopulations 
African (AFR) 
 AF: 
AC: 
1
AN: 
41350
American (AMR) 
 AF: 
AC: 
0
AN: 
15260
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
0
AN: 
3468
East Asian (EAS) 
 AF: 
AC: 
0
AN: 
5192
South Asian (SAS) 
 AF: 
AC: 
0
AN: 
4814
European-Finnish (FIN) 
 AF: 
AC: 
0
AN: 
10592
Middle Eastern (MID) 
 AF: 
AC: 
0
AN: 
316
European-Non Finnish (NFE) 
 AF: 
AC: 
0
AN: 
68000
Other (OTH) 
 AF: 
AC: 
0
AN: 
2088
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.425 
Heterozygous variant carriers
 0 
 0 
 1 
 1 
 2 
 2 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Genome Het
Variant carriers
 0 
 2 
 4 
 6 
 8 
 10 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
Alfa 
 AF: 
Hom.: 
Bravo 
 AF: 
ClinVar
Significance: Uncertain significance 
Submissions summary: Uncertain:1 
Revision: criteria provided, single submitter
LINK: link 
Submissions by phenotype
not provided    Uncertain:1 
May 08, 2015
Eurofins Ntd Llc (ga)
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source: 
Name
Calibrated prediction
Score
Prediction
 AlphaMissense 
 Pathogenic 
 BayesDel_addAF 
 Pathogenic 
D 
 BayesDel_noAF 
 Uncertain 
 DANN 
 Uncertain 
 DEOGEN2 
 Uncertain 
D 
 Eigen 
 Uncertain 
 Eigen_PC 
 Uncertain 
 FATHMM_MKL 
 Pathogenic 
D 
 LIST_S2 
 Benign 
T 
 M_CAP 
 Uncertain 
D 
 MetaRNN 
 Pathogenic 
D 
 MetaSVM 
 Uncertain 
D 
 MutationAssessor 
 Pathogenic 
M 
 PhyloP100 
 PrimateAI 
 Uncertain 
T 
 PROVEAN 
 Pathogenic 
D 
 REVEL 
 Uncertain 
 Sift 
 Pathogenic 
D 
 Sift4G 
 Uncertain 
D 
 Polyphen 
D 
 Vest4 
 MutPred 
Loss of ubiquitination at K171 (P = 0.0716);
 MVP 
 MPC 
 ClinPred 
D 
 GERP RS 
 Varity_R 
 gMVP 
Splicing
Name
Calibrated prediction
Score
Prediction
 SpliceAI score (max) 
Details are displayed if max score is > 0.2
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at 
Publications
 You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.